INTERNATIONAL PATENT: LEGEND BIOTECH IRELAND LIMITED, LI, TIANJIAN FILES APPLICATION FOR "CELLS OVEREXPRESSING B3GNT2 AND METHODS OF USE THEREOF"

GENEVA, March 19 -- LEGEND BIOTECH IRELAND LIMITED (10A Ballymoss Road, Sandyford Business ParkDublin 18, D18 T934), LI, Tianjian (Piscataway, New Jersey) filed a patent application (PCT/US2025/044658) for "CELLS OVEREXPRESSING B3GNT2 AND METHODS OF USE THEREOF" on Sep 03, 2025. With publication no. WO/2026/055226, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LING, Weifang (Piscataway, New Jersey), CHU, Jianhua (Piscataway, New Jersey)

Abstract: Provided herein are engineered cells overexpressing a UDP-GlcNAc:betaGal ...